Match!
Pierre Delanaye
University of Liège
EndocrinologyRenal functionCreatinineDiabetes mellitusMedicine
507Publications
34H-index
3,994Citations
What is this?
Publications 521
Newest
#1Jonas Björk (Lund University)H-Index: 41
#2Ulf Nyman (Lund University)H-Index: 36
Last. Cyril GarrousteH-Index: 11
view all 28 authors...
Source
Source
#1Christophe BovyH-Index: 7
#2Pierre DelanayeH-Index: 34
Last. Krzesinski JmH-Index: 3
view all 4 authors...
Chronic kidney disease (CKD) impairs the quality of life and increases the risk for cardiovascular morbimortality. Intensive research is conducted in order to slow down CKD development and progression. During the past decade, a better understanding of the pathophysiological mechanisms of glomerular diseases has highlighted the benefits of rituximab. Progresses have also been made in the understanding of the mechanisms of autosomal polycystic kidney disease, the most frequent inherited kidney dis...
#1Pierre Delanaye (University of Liège)H-Index: 34
#2Laurence DubourgH-Index: 25
Last. D. Monnet (UCA: Université Félix Houphouët-Boigny)H-Index: 6
view all 13 authors...
Source
#1Guillaume Résimont (University of Liège)
#2Laurence PiéroniH-Index: 8
Last. Pierre Delanaye (University of Liège)H-Index: 34
view all 5 authors...
Urine samples can be readily obtained from patients in everyday clinical practice. Therefore, the availability of urine allows physicians to obtain relevant clinical information in a timely manner. Since the measurement of urinary protein levels is essential in diagnosing and treating a host of diseases, the potential detection of urinary proteins by urinary strips in an easy, quick, and cheap way is very attractive. However, to ensure optimal use of urinary strips, one needs to be aware of thei...
Source
#1Hans Pottel (Katholieke Universiteit Leuven)H-Index: 24
Last. Pierre Delanaye (University of Liège)H-Index: 34
view all 5 authors...
Source
#1Etienne Cavalier (University of Liège)H-Index: 30
#2Pierre Lukas (University of Liège)H-Index: 7
Last. Pierre DelanayeH-Index: 34
view all 6 authors...
Abstract Introduction: Non-oxidized (n-ox) PTH could better reflect PTH activity. We have evaluated the evolution of n-ox PTH and intact PTH (iPTH) in HD patients over a period of 1 year. Material and methods We measured iPTH and n-ox PTH in 66 stable HD patients were enrolled and we measured iPTH and n-ox PTH at baseline and after 1,3,6 and 12 months. We considered that no significant changes in iPTH and n-ox PTH occurred if two consecutives measurements of iPTH and n-ox PTH for the same patien...
Source
#2Peter Evenepoel (Katholieke Universiteit Leuven)
Last. Pierre DelanayeH-Index: 34
view all 6 authors...
Abstract Sclerostin is sometimes presented as a promising biomarker in assessing bone health both in the general population and chronic kidney disease patients. However, it is still unclear whether it has any true added value compared to existing bone biomarkers in predicting bone turnover and/or bone density in chronic kidney disease patients. A wealth of papers has been published to evaluate the association between sclerostin and vascular calcifications development or even as prognostic biomar...
Source
#1Vincent Castiglione (United Laboratories)
#2Hans Pottel (University of Liège)H-Index: 28
Last. Andrew D. Rule (Mayo Clinic)H-Index: 42
view all 7 authors...
Background Matrix-Gla-protein (MGP) is an inhibitor of vascular calcification. Its dephosphorylated and uncarboxylated inactive form, dpucMGP, is a marker of vitamin K status and of cardio-vascular outcomes in chronic kidney disease. We hypothesized that higher serum dpucMGP would be a biomarker of kidney stone disease.
Source
#1Christophe BovyH-Index: 7
#2Pierre DelanayeH-Index: 34
Last. Jean-Marie KrzesinskiH-Index: 28
view all 4 authors...
12345678910